Navigation Links
Reportlinker Adds World Influenza Vaccines Market 2011-2021
Date:4/5/2011

th Rates (%) for Novartis, 2016-2021

Table 4.12 Fluvirin: Drivers and Restraints, 2010-2021

Table 4.13 Global Sales Revenues ($bn) and Growth Rates (%) for Fluvirin, 2009-2015

Table 4.14 Global Sales Revenues ($bn) and Growth Rates (%) for Fluvirin, 2016-2021

Table 4.15 Global Influenza Vaccine Sales Revenues ($bn) and Growth Rates (%) for GlaxoSmithKline, 2009-2015

Table 4.16 Global Influenza Vaccine Sales Revenues ($bn) and Growth Rates (%) for GlaxoSmithKline, 2016-2021

Table 4.17 Fluviral/FluLaval: Drivers and Restraints, 2010-2021

Table 4.18 Global Sales Revenues ($bn) and Growth Rates (%) for FluLaval/Fluviral, 2009-2015

Table 4.19 Global Sales Revenues ($bn) and Growth Rates (%) for FluLaval/Fluviral, 2016-2021

Table 4.20 Fluarix: Drivers and Restraints, 2010-2021

Table 4.21 Global Sales Revenues ($bn) and Growth Rates (%) for Fluarix, 2010-2015

Table 4.22 Global Sales Revenues ($bn) and Growth Rates (%) for Fluarix, 2016-2021

Table 4.23 Potential Worldwide Influenza Vaccine Manufacturers, 2010

Table 4.24 Other Key Influenza Vaccine Manufacturers in Mature Markets, 2010

Table 4.25 Global Influenza Vaccine Sales Revenues ($bn) and Growth Rates (%) for Other Manufacturers, 2009-2015

Table 4.26 Global Influenza Vaccine Sales Revenues ($bn) and Growth Rates (%) for Other Manufacturers, 2016-2021

Table 4.27 Global Sales Revenues ($bn) and Growth Rates (%) for Influvac, Flumist and Inflexal, 2009-2015

Table 4.28 Global Sales Revenues ($bn) and Growth Rates (%) for Influvac, Flumist and Inflexal, 2016-2021

Table 4.29 Projected Global Manufacturing Capacities (Doses) for Key Players, 2012

Table 5.1 Influenza Vaccine Sales Revenues ($bn) and Growth Rates (%) for Mature Markets, 2009-2015

Table 5.2 Influenza Vaccine Sales Revenues ($bn) and Growth Rates (%) for Mature Markets, 2016-2021

Table 5.3 Influenza Vaccine Sales Reve
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Reportlinker Adds Drug Delivery in Cancer - technologies, markets and companies
2. Reportlinker Adds Enzymes in Drug Manufacturing
3. Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects
4. Reportlinker Adds Pain Therapeutics - Drugs, Markets and Companies
5. Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing
6. Reportlinker Adds Top 500 Pharmaceuticals Industry Report (Global)
7. Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market
8. Reportlinker Adds Top 200 Biopharmaceuticals Industry Report (Global)
9. Reportlinker Adds Butadiene Market In Americas To 2020 - Recovery In End Use Markets Providing Positive Demand Growth In The Region
10. Reportlinker Adds Medical Imaging Markets
11. Reportlinker Adds Cardiac Marker Diagnostic Testing Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) today reported financial ... "During the quarter, we achieved a key ... securing a partner to accelerate the development and commercialization of ... we do not have a commercial presence while also retaining ... the value of PIXUVRI for CTI and help us achieve ...
(Date:10/30/2014)... -- Today Eli Lilly and Company (NYSE: ... program to increase the global supply of medicines for ... Lilly donating manufacturing technology and know-how for two antibiotics ... India , Russia ... all MDR-TB ,hot spots., It also served as the ...
(Date:10/27/2014)... NEW YORK , Oct. 27, 2014  In the last ... parts of Africa to a worldwide crisis ... down with the virus and died, and two nurses were infected. ... how this could happen, the use of modern technology, such as ... went largely unnoticed. This week, InformationWeek Healthcare Editor ...
Breaking Medicine Technology:CTI BioPharma Reports Third Quarter 2014 Financial Results 2CTI BioPharma Reports Third Quarter 2014 Financial Results 3CTI BioPharma Reports Third Quarter 2014 Financial Results 4CTI BioPharma Reports Third Quarter 2014 Financial Results 5CTI BioPharma Reports Third Quarter 2014 Financial Results 6CTI BioPharma Reports Third Quarter 2014 Financial Results 7CTI BioPharma Reports Third Quarter 2014 Financial Results 8CTI BioPharma Reports Third Quarter 2014 Financial Results 9CTI BioPharma Reports Third Quarter 2014 Financial Results 10CTI BioPharma Reports Third Quarter 2014 Financial Results 11CTI BioPharma Reports Third Quarter 2014 Financial Results 12Lilly Shares Insights from Decade-Long Technology Transfer Experience 2Lilly Shares Insights from Decade-Long Technology Transfer Experience 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 4EHRs in the Age of Ebola: Discuss on InformationWeek 2EHRs in the Age of Ebola: Discuss on InformationWeek 3
... ROCKVILLE, Md., July 6 A procedure that sends targeted ... to treat a common type of irregular heartbeat, but little ... methods and circumstances for applying it, according to a new ... , , The report examines the use of a ...
... The Netherlands, July 6 Three new small and,medium ... - have joined public-private partnership TI Pharma by,participating in ... diseases, have a total budget of nearly 6 million ... formed by Syncom, Synvolux Therapeutics, and,University Medical Center Groningen, ...
Cached Medicine Technology:New AHRQ Study Finds Mixed Evidence on Use of Radiofrequency Catheter Ablation for Treating Atrial Fibrillation 2New AHRQ Study Finds Mixed Evidence on Use of Radiofrequency Catheter Ablation for Treating Atrial Fibrillation 3New Small and Medium Sized Enterprises Join TI Pharma by Signing Two New Projects 2
(Date:10/30/2014)... REV'D Provision Co. announced today that REV’D® ... unique service called, The Feed . The Feed ... athlete. The Feed has taken the nutritional knowledge used ... to pass that information on to the everyday athlete. ... on The Feed!” says REV’D® marketing manager Matt O’Connor. ...
(Date:10/30/2014)... The Woodlands, TX (PRWEB) October 30, 2014 ... hospital system, released today its 2014 third quarter ... hospitals across Texas boasted infection rates of only ... also reported patient satisfaction scores exceeding 98 percent. ... this past quarter, which included rising satisfaction scores,” ...
(Date:10/30/2014)... WEDNESDAY, Oct. 29, 2014 (HealthDay News) -- Scientists who ... the laboratory say their breakthrough could provide a new ... of stomach diseases. The team used human pluripotent ... cell in the body -- to grow the functional ... bacteria, a major cause of ulcers and stomach ...
(Date:10/30/2014)... WEDNESDAY, Oct. 29, 2014 (HealthDay News) -- Many ... near campus, even though tanning increases the risk ... popular among young adults, particularly white women, so ... students, health, the researchers said. "Public health ... student population awareness of the harms that indoor ...
(Date:10/30/2014)... News) -- A new vaccine that could help prevent ... by the U.S. Food and Drug Administration on Wednesday. ... ages of 10 and 25 from invasive meningococcal disease ... The bacteria can infect the bloodstream (sepsis) and ... It is a leading cause of bacterial meningitis, and ...
Breaking Medicine News(10 mins):Health News:Nutrition Experts at TheFeed.com Get REV'D 2Health News:Nutrition Experts at TheFeed.com Get REV'D 3Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 3Health News:Many U.S. Colleges Have Indoor Tanning Salons On, Near Campus: Study 2Health News:FDA Approves New Vaccine to Protect Against Meningitis 2
... In a survey of patients with chronic hepatitis C ... Digestive and Kidney Diseases-sponsored long-term treatment trial for patients ... approximately 40% acknowledged to interviewers at the time of ... the recent past used herbal products for health purposes. ...
... (TSX: MDS; NYSE:,MDZ), a leading provider of products ... filed restated 2007 quarterly reports under US GAAP,as ... 2007,annual report and financial statements in US GAAP ... restated quarterly reports also correct an error related ...
... APFC ) today announced that it will release ... 7, 2008. John R.,Gibson, Chairman and Chief Executive Officer, ... financial results and outlook of the,Company., The teleconference ... p.m.,PST. To access the call please dial (973) 582-2852 ...
... The Chrysler Foundation and,Kenosha (Wis.) Engine Plant today ... new Aquatics Center., Chrysler,s donation will help build ... the YMCA. The center will have two pools: a ... YMCA will break,ground for the aquatic center later this ...
... Iowa An anti-virus drug attacks influenza A by changing ... the virus to infect healthy cells, according to a recently ... Mei Hong, Iowa States John D. Corbett Professor in Chemistry, ... the effects of the antiviral drug amantadine on influenza A. ...
... research,organization, announced today that it has acquired the business ... located at Ninewells,Hospital and Medical School, Dundee, Scotland. Ninewells ... purchase of DDS supplements,Chiltern,s Clinical Research Unit in Slough ... has completed more than 700 Phase I trials.,The unit ...
Cached Medicine News:Health News:Silymarin does not affect virus activity or ALT levels in 2Health News:Silymarin does not affect virus activity or ALT levels in 3Health News:American Pacific to Release Financial Results and Hold Fiscal 2008 First Quarter Investor Teleconference 2Health News:The Chrysler Foundation and Kenosha Engine Plant Donate $100,000 to New YMCA Aquatics Center 2Health News:Iowa State chemists track how drug changes, blocks flu virus 2Health News:Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS) 2Health News:Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS) 3
... manual hemostasis analyzer that is ideal ... PTs, aPTTs, thrombins, fibrinogens and factor ... testing, this analyzer is small in ... time and labor saving benefits. Operation ...
... STart benchtop coagulation analyzers feature ... clot detection. This method eliminates ... other optically dense samples or ... and preprogrammed assays with curve ...
... Description,The STA-R Evolution is a fully-automated, ... the total laboratory automation line. Clotting, ... simultaneously in random access mode. The ... offers high throughput and rapid processing ...
The ACL 9000 together with an extensive test menu and superior technology is backed by high-quality service to keep the lab running efficiently....
Medicine Products: